Publications by authors named "Hans Brunner"

Claim this Profile
S
Safety and efficacy of once-daily dexfadrostat phosphate in patients with primary aldosteronism: a randomised, parallel group, multicentre, phase 2 trial.
Paolo Mulatero, Gregoire Wuerzner, Michael Groessl, Elisa Sconfienza, Aikaterini Damianaki, Hans Brunner

EClinicalMedicine· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cell-type-specific representation of spatial context in the rat prefrontal cortex.
Hans Brünner, Hoseok Kim, Sofie Ährlund-Richter, Josina Anna van Lunteren, Ana Paula Crestani

iScience· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Linking QKD Testbeds across Europe.
Max Brauer, Rafael J Vicente, Jaime S Buruaga, Rubén B Méndez, Ralf-Peter Braun, Hans H Brunner

Entropy (Basel)· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Robotic arm training in neurorehabilitation enhanced by augmented reality - a usability and feasibility study.
Alexandra Charlotte de Crignis, Salome-Thamar Ruhnau, Matthias Hösl, Jérémy Lefint, Tamara Amberger, Hans Brunner

J Neuroeng Rehabil· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The DMCdrive: practical 3D-printable micro-drive system for reliable chronic multi-tetrode recording and optogenetic application in freely behaving rodents.
Hoseok Kim, Hans Sperup Brünner, Marie Carlén

Sci Rep· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Does Size Really Matter? The Role of Tonotopic Map Area Dynamics for Sound Learning in Mouse Auditory Cortex.
Hans Sperup Brünner, Rune Rasmussen

eNeuro· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quantitative Gd-DOTA uptake from cerebrospinal fluid into rat brain using 3D VFA-SPGR at 9.4T.
Hedok Lee, Kristian Mortensen, Simon Sanggaard, Palle Koch, Hans Brunner

Magn Reson Med· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Angiotensin II type 1 receptor antagonists in animal models of vascular, cardiac, metabolic and renal disease.
Martin C Michel, Hans R Brunner, Carolyn Foster, Yong Huo

Pharmacol Ther· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Aldosterone synthase inhibition for the treatment of hypertension and the derived mechanistic requirements for a new therapeutic strategy.
Christoph D Schumacher, Ronald E Steele, Hans R Brunner

J Hypertens· October 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A systematic comparison of the properties of clinically used angiotensin II type 1 receptor antagonists.
Martin C Michel, Carolyn Foster, Hans R Brunner, Lisheng Liu

Pharmacol Rev· April 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cardiovascular outcomes in hypertensive patients: comparing single-agent therapy with combination therapy.
Michael A Weber, Stevo Julius, Sverre E Kjeldsen, Yan Jia, Hans R Brunner

J Hypertens· November 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antihypertensive efficacy of olmesartan medoxomil and candesartan cilexetil assessed by 24-hour ambulatory blood pressure monitoring in patients with essential hypertension.
Hans R Brunner, Klaus O Stumpe, Andrzej Januszewicz

Clin Drug Investig· October 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Usefulness of heart rate to predict cardiac events in treated patients with high-risk systemic hypertension.
Stevo Julius, Paolo Palatini, Sverre E Kjeldsen, Alberto Zanchetti, Michael A Weber, Hans R Brunner

Am J Cardiol· March 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Practical solutions to the challenges of uncontrolled hypertension: a white paper.
Josep Redon, Hans R Brunner, Claudio Ferri, Karl F Hilgers, Rainer Kolloch

J Hypertens Suppl· December 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Acute cortisol administration increases sleep depth and growth hormone release in patients with major depression.
Dagmar A Schmid, Hans Brunner, Christoph J Lauer, Manfred Uhr, Alexander Yassouridis

J Psychiatr Res· October 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dex/CRH-test response and sleep in depressed patients and healthy controls with and without vulnerability for affective disorders.
Elisabeth Friess, Dagmar Schmid, Sieglinde Modell, Hans Brunner, Christoph J Lauer

J Psychiatr Res· October 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Munich vulnerability study on affective disorders: microstructure of sleep in high-risk subjects.
Elisabeth Friess, Sieglinde Modell, Hans Brunner, Hirokuni Tagaya, Christoph J Lauer

Eur Arch Psychiatry Clin Neurosci· August 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Under pressure: future prospects in hypertension management. Interview by Laura Dormer.
Hans R Brunner

Expert Rev Cardiovasc Ther· August 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Aliskiren: the first renin inhibitor for clinical treatment.
Chris Jensen, Peter Herold, Hans Rudolf Brunner

Nat Rev Drug Discov· May 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evolution and hypertension: is the Renin system necessary?
Haralambos Gavras, Hans R Brunner

Hypertension· June 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Olmesartan medoxomil: current status of its use in monotherapy.
Hans R Brunner

Vasc Health Risk Manag· March 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antihypertensive efficacy of olmesartan medoxomil and candesartan cilexetil in achieving 24-hour blood pressure reductions and ambulatory blood pressure goals.
Hans R Brunner, Kikuo Arakawa

Clin Drug Investig· February 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
p63-associated disorders.
Tuula Rinne, Hans G Brunner, Hans van Bokhoven

Cell Cycle· February 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Validation of in-vitro data by in-vivo evidence: the example of angiotensin (1-7).
Hans R Brunner, Haralambos Gavras

J Hypertens· October 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Valsartan Antihypertensive Long-Term Use Evaluation (VALUE) trial: outcomes in patients receiving monotherapy.
Stevo Julius, Michael A Weber, Sverre E Kjeldsen, Gordon T McInnes, Alberto Zanchetti, Hans R Brunner

Hypertension· September 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis